Colby Stong

Researchers sought to determine if risk factors for cardiovascular disease and complications changed during different phases of the COVID-19 pandemic.

Researchers sought to evaluate responses to bimekizumab therapy over 3 years in patients with moderate-to-severe plaque psoriasis.

Researchers sought to assess the efficacy of upadacitinib monotherapy for the treatment of alopecia areata.

Researchers assessed how improvements in clinical responses are associated with improvements in patient-reported outcomes and quality of life in atopic dermatitis.

Investigators assessed changes in the circulation of respiratory viruses during multiple early waves of the COVID-19 pandemic.

Researchers sought to evaluate implementation of protocolized biologic dose reduction in psoriasis.

Researchers sought to examine immune-mediated and androgen-mediated skin diseases associated with metformin.

Researchers tested wastewater collected during the COVID-19 pandemic to assess the value of using RT-PCR assays targeting respiratory viral genomes on wastewater.

Researchers identified cytokines and other inflammatory blood biomarkers that could be used to predict and distinguish between SARS-CoV-2 vs influenza infection.

Researchers sought to compare clinical outcomes of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with plasmapheresis first vs intravenous immunoglobulin.

Researchers evaluated disease control in patients with moderate-to-severe atopic dermatitis.

Researchers assessed the prevalence, efficacy, and safety of narrowband ultraviolet B phototherapy.

Researchers assessed the accuracy of a traditional statistical risk factor-based model versus machine learning in predicting the 5-year probability of biologic discontinuation.

Researchers studied the epidemiology of COVID-19 viral and symptom rebound in patients with acute COVID-19 infection who received nirmatrelvir plus ritonavir.

Researchers evaluated the use of anti-interleukin (IL)-17A biologics among patients with moderate to severe psoriasis.

A systematic review and meta-analysis assessed the duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract.

Researchers sought to determine the prevalence and bidirectional associations of atopic dermatitis with food sensitivity and food allergies.

Researchers sought to characterize the evolution of blue nevi and assess the need for monitoring.

A study was conducted to determine the relationship between resting heart rate and cardiovascular events in patients with type 2 diabetes.

A prospective study of patients post severe-to-critical COVID-19 identified and explored the determinants of patients’ lung-function recovery trajectories.

Researchers assessed the accuracy and biases of 4 pulse oximeters used in clinical practice by comparing their SpO2 readings with concomitant SaO2 measurements.

Investigators conducted a systematic review and meta-analysis to assess the relationship between hidradenitis suppurativa and allergic conditions.

Researchers evaluated the relationship between dietary inflammatory potential and the risk for psoriasis.

Researchers sought to determine the survival implications of cutaneous immune-related adverse events in patients who receiving immune checkpoint inhibitors.

A team of investigators sought to identify factors contributing to sleep disturbance in patients with atopic dermatitis.

Researchers sought to determine the prevalence of endothelial dysfunction in patients with CVD and history of COVID-19 infection.

Investigators conducted an open-label, prospective, phase 2 study to assess treatment with a combination of apremilast and dupilumab among patients with atopic dermatitis.

Investigators examined the relationship between lymphopenia and infection risk among patients with atopic dermatitis.

Researchers evaluated the prevalence of advanced fibrosis and cirrhosis secondary to nonalcoholic fatty liver disease in older adult patients.

A meta-analysis assessed exercise capacity, as measured by CPET, more than 3 months after COVID-19 infection in those with and without long COVID symptoms.